期刊文献+

不同期糖尿病肾病患者肾小球电荷屏障变化与HbA1c相关性研究

Correlated study on the change of glomerular charge barrier in different stages of diabetic nephropathy and the influencing factor HbA1c
暂未订购
导出
摘要 目的:观察不同期DN患者肾小球电荷屏障的变化及与Hb A1c相关性。方法:80例DM住院患者分为4组:DM正常白蛋白尿组(n=20)、DNⅢ期组(n=20),DNⅣ期组(n=20)和DNⅤ期组(n=20),另选性别、年龄大致相匹配的健康志愿者作为健康对照组(n=20)。测定各组血清和尿液中胰淀粉酶、唾液粉酶含量,比较各组胰淀粉酶清除率(CPAM)与唾液淀粉酶清除率(CSAM)的比值(CPAM/CSAM),评估各组肾小球电荷屏障的变化情况。应用双变量线性相关分析CPAM/CSAM与Hb A1c的相关性。结果:各组中CPAM/CSAM值DM正常白蛋白尿组、DNⅢ期组和DNⅣ组间两两比较差异均有统计学意义(P<0.05);DM正常白蛋白尿组与健康对照组间差异无统计学意义(P>0.05),DNⅣ期组与DNⅤ期组间差异无统计学意义(P>0.05)。CPAM/CSAM值与Hb A1c具有负相关性(r=-0.78,P<0.05)。结论:DM患者随着DN病程的进展,肾小球电荷屏障损伤逐渐加重,降低Hb A1c或能延缓肾小球电荷屏障的损伤。 Objective: To observe the change of glomerular charge barrier in different stages of diabetic nephropathy (DN) and its correlation with HbAlc. Methods: 80 hospitalized patients with diabetes meUims (DM) were divided into four groups: 20 diabetic patients with normal urinary albumin excretion, 20 patients with DN in stage IU, 20 patients with DN in stage Ⅳ and 20 patients with DN in stage Ⅴ. And 20 healthy volunteers with similar age and sex were chosen as the control group. Then pancreatic amylase and salivary amylase of serum and urine in each group were determined and CPAM/CSAM was calculated for evaluating the changes of glomerular charge barrier in each group. Next, the means of CPAM / CSAM among different groups were compared, and the correlation between CPAM/CSAM and HbAlc was analyzed. Results: There were significant differences among three groups: DM with normal urinary albumin excretio, DN in stage Ⅲ and DN in stage Ⅳ( P〈 0.05);there was no significant difference between the DM group with normal urinary albumin excretio and the control group (P〉0.05); and there was no statistical difference between the DN groups in stage 1V and DN group in stage V (P〉0.05). Moreover, there was a negative correlation between the value of CPAM/CSAM and HbAlc (r = -0.78, P〈 0.05 ). Conclusion: With the progress of the DN course, the damage of glomerular charge barrier of the DM patients becomes worse and worse. Therefore, to a certain degree, the reduction of HbAlc may delay the damage of glomerular charge barrier.
出处 《华夏医学》 CAS 2016年第4期55-58,共4页 Acta Medicinae Sinica
关键词 糖尿病肾病 肾小球电荷屏障 糖化血红蛋白 diabetic nephropathy (DN) glomerular charge barrier HbAlc
  • 相关文献

参考文献7

  • 1Xu Y, Wang L, He J, et al. Prevalence and control of diabe- tes in Chinese adults [J]. JAMA, 2013, 310(9): 948-959.
  • 2姜新献,陈重义.研究肾小球电荷屏障方法的概况[J].国外医学(泌尿系统分册),1990,10(6):257-260. 被引量:5
  • 3Fox J G, Quin J D, O'reilly D S, et al. Assessment of glo- merular charge selectivity in man by differential clearance of isoamylases [ J ]. Clinical Science, 1993, 84(Pt 4): 449-454.
  • 4Packham D K, Alves T P, Dwyer J P, et al. Relative inci- dence of ESRD versus cardiovascular mortality in protein- uric type 2 diabetes and nephropathy: results from the DI- AMETRIC (Diabetes Mellitus Treatment for Renal Insuffi- ciency Consortium) database [ J ] .American Journal of Kid- ney Diseases, 2012, 59(1): 75-83.
  • 5Pavkov M E, Knowler W C, Lemley K V, et al. Early renal function decline in type 2 diabetes [ J ]. Clinical Journal of the American Society of Nephrology, 2012, 7(1): 78-84.
  • 6Hafkenscheid J C, Wetzels J F, Hessels M, et al. Renal clearance of pancreatic and salivary amylase relative to creatinine clearance in patients with renal disease and pro- teinuria [ J ]. Clinical chemistry, 1988, 34(3): 589-591.
  • 7Penno G, Solini A, Bonora E, et al. HbAlc variability as an independent correlate of nephropathy, but not retinopa- thy, in patients with type 2 diabetes the renal insufficiency and cardiovascular events (RIACE) italian multicenter study [ J ]. Diabetes Care, 2013, 36(8): 2301-2310.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部